US2020131555A1PendingUtilityA1
Incorporation of unnatural nucleotides and methods thereof
Est. expiryJul 11, 2037(~11 yrs left)· nominal 20-yr term from priority
Inventors:Jerod PtacinCarolina E. CaffaroHans AerniYorke ZhangEmil C. FischerAaron W. FeldmanVivian T. DienFloyd E. Romesberg
C12N 15/90C12N 15/113C12N 9/93C12P 21/02C12Y 601/01026C12N 15/11
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
Claims
exact text as granted — not AI-modified1 .- 23 . (canceled)
24 . An E. coli cell comprising:
(a) a nucleoside triphosphate transporter from Phaeodactylum tricornutum; (b) an mRNA comprising an unnatural base comprising a structure selected from
(c) a tRNA comprising an unnatural base comprising a structure selected from
and
(d) an aminoacyl tRNA synthetase derived from an organism selected from the group consisting of Methanosarcina barkeri and Methanococcus jannaschii.
25 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the mRNA.
26 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the tRNA.
27 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase.
28 . The E. coli cell of claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA and the tRNA.
29 . The E. coli cell of claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA, the tRNA, and the aminoacyl tRNA synthetase.
30 . The E. coli cell of claim 24 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
31 . The E. coli cell of claim 30 , wherein the mRNA comprises the codon AXC.
32 . The E. coli cell of claim 31 , wherein the unnatural base comprises the structure
33 . The E. coli cell of claim 31 , wherein the unnatural base comprises the structure
34 . The E. coli cell of claim 30 , wherein the mRNA comprises the codon GXC.
35 . The E. coli cell of claim 34 , wherein the unnatural base comprises the structure
36 . The E. coli cell of claim 34 , wherein the unnatural base comprises the structure
37 . The E. coli cell of claim 24 , wherein the aminoacyl tRNA synthetase is derived from Methanosarcina barkeri.
38 . The E. coli cell of claim 36 , wherein the mRNA comprises an unnatural base comprising the structure
and the tRNA comprises an unnatural base comprising the structure
39 . The E. coli cell of claim 37 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
40 . The E. coli cell of claim 24 , wherein the aminoacyl tRNA synthetase is derived from Methanococcus jannaschii.
41 . The E. coli cell of claim 39 , wherein the mRNA comprises an unnatural base comprising the structure
and the tRNA comprises an unnatural base comprising the structure
42 . The E. coli cell of claim 40 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
43 . The E. coli cell of claim 24 , wherein the tRNA is derived from an organism selected from the group consisting of Methanosarcina barkeri and Methanococcus jannaschii.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.